Letters Section Editor: Robert M. Golub,
MD, Senior Editor.
To the Editor: Dr Carrat and colleagues1 compared ribavirin combined with either pegylated
interferon or standard interferon for treatment of hepatitis C in patients
infected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV).
Their results are consistent with previous studies in HIV-seronegative persons,
which showed that viral load reduction correlates with improvement in hepatic
function.2 However, there are 2 issues I would
like to address.
Menkes DL. Pegylated Interferon vs Standard Interferon for Chronic Hepatitis C. JAMA. 2005;293(11):1323-1324. doi:10.1001/jama.293.11.1323-a